🔗 Share this article

This year's Nobel Prize in medical science has been granted for transformative findings that clarify how the body's defense network targets dangerous infections while protecting the healthy tissues.

Three esteemed researchers—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this honor.

Their research uncovered unique "sentinels" within the immune system that eliminate rogue defense cells that could attacking the body.

These findings are now paving the way for innovative therapies for autoimmune diseases and cancer.

The winners will share a prize fund valued at 11m Swedish kronor.

Decisive Discoveries

"Their research has been decisive for understanding how the immune system functions and the reason we don't all suffer from severe self-attack conditions," stated the head of the award panel.

The trio's studies address a fundamental question: In what way does the defense system defend us from numerous infections while leaving our healthy cells unharmed?

The immune system employs immune cells that scan for signs of disease, including pathogens and bacteria it has not met before.

These cells employ detectors—called receptors—that are produced randomly in a vast number of variations.

This provides the defense network the ability to combat a broad range of invaders, but the randomness of the mechanism inevitably creates white blood cells that may target the body.

Security Guards of the Immune System

Researchers previously knew that a portion of these problematic white blood cells were eliminated in the thymus—where immune cells mature.

This year's award honors the discovery of T-reg cells—described as the body's "security guards"—which patrol the system to neutralize any immune cells that assault the healthy cells.

We know that this process fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

The Nobel panel stated, "The findings have established a new field of investigation and spurred the creation of new treatments, for example for tumors and immune disorders."

Regarding malignancies, regulatory T-cells block the system from attacking the growth, so research are focused on reducing their quantity.

In autoimmune diseases, trials are exploring boosting T-reg cells so the body is no longer being harmed. A similar method could also be useful in minimizing the risks of organ transplant failure.

Innovative Studies

Prof Shimon Sakaguchi, from a Japanese institution, conducted tests on mice that had their thymus extracted, leading to self-attack conditions.

He demonstrated that injecting defense cells from other animals could stop the illness—implying there was a mechanism for preventing immune cells from harming the host.

Dr. Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic autoimmune disease in mice and humans that led to the discovery of a gene vital for the way regulatory T-cells function.

"Their groundbreaking research has uncovered how the immune system is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," commented a prominent physiology expert.

"This research is a striking example of how basic physiological research can have far-reaching consequences for human health."